Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Mesh.i » - entrée « Oseltamivir »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Orthomyxoviridae Infections < Oseltamivir < Osteoarthritis  Facettes :

List of bibliographic references indexed by Oseltamivir

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]
Ident.Authors (with country if any)Title
000031 (2021) Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie]Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
000035 (2021) L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A MarcialisWhat if COVID-19 affects the child: which weapons and how to use them.
000060 (2021) Diana Laila Ramatillah [Indonésie] ; Suri Isnaini [Indonésie]Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta.
000158 (2021) Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte]Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
000253 (2021) Leila Simani [Iran] ; Mahtab Ramezani [Iran] ; Ilad Alavi Darazam [Iran] ; Mastooreh Sagharichi [Iran] ; Mohammad Amin Aalipour [Iran] ; Fatemeh Ghorbani [Iran] ; Hossein Pakdaman [Iran]Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
000281 (2021) Nader Bakheet [Égypte] ; Rabab Fouad [Égypte] ; Abdel Meguid Kassem [Égypte] ; Wessam Hussin [Égypte] ; Mostafa El-Shazly [Égypte]Persistent hiccup: A rare presentation of COVID-19.
000293 (2021) Maziar Emamikhah [Iran] ; Mansoureh Babadi [Iran] ; Mehrnoush Mehrabani [Iran] ; Mehdi Jalili [Iran] ; Maryam Pouranian [Iran] ; Peyman Daraie [Iran] ; Fahimeh Mohaghegh [Iran] ; Sharmin Aghavali [Iran] ; Maryam Zaribafian [Iran] ; Mohammad Rohani [Iran]Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
000483 (2021) Jesús Arturo Ruíz-Qui Onez [Mexique] ; Crystell Guadalupe Guzmán-Priego [Mexique] ; Germán Alberto Nolasco-Rosales [Mexique] ; Carlos Alfonso Tovilla-Zarate [Mexique] ; Oscar Israel Flores-Barrientos [Mexique] ; Víctor Narváez-Osorio [Mexique] ; Guadalupe Del Carmen Baeza-Flores [Mexique] ; Thelma Beatriz Gonzalez-Castro [Mexique] ; Carlos Ram N L Pez-Brito [Mexique] ; Carlos Alberto Denis-García [Mexique] ; Agustín Pérez-García [Mexique] ; Isela Esther Juárez-Rojop [Mexique]Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
000531 (2021) Zerrin Orbak [Turquie] ; Fuat Laloglu [Turquie] ; Hulya Akat [Turquie]Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
000534 (2021) Burcu U Urlu Ilg N ; Rem Müge Akbulut Koyuncu ; Emrullah K Z LtunçEffect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
000729 (2021) Ambedkar Kumar Yadav [République populaire de Chine] ; Siwan Wen [République populaire de Chine] ; Xianghuai Xu [République populaire de Chine] ; Li Yu [République populaire de Chine]Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
000754 (2021) Setareh Mamishi [Iran] ; Ameneh Navaeian [Iran] ; Reza Shabanian [Iran]Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
000762 (2021) Jiahong Tan [République populaire de Chine] ; Yuan Yuan [République populaire de Chine] ; Cheng Xu [République populaire de Chine] ; Chunyan Song [République populaire de Chine] ; Dan Liu [République populaire de Chine] ; Ding Ma [République populaire de Chine] ; Qinglei Gao [République populaire de Chine]A retrospective comparison of drugs against COVID-19.
000884 (2020) Muayad A. Merza [Iraq] ; Azad A. Haleem Al Mezori [Iraq] ; Hakar Mustafa Mohammed [Iraq] ; Deldar Morad Abdulah [Iraq]COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease.
000B26 (2020) Ensieh Vahedi [Iran] ; Mostafa Ghanei [Iran] ; Ali Ghazvini [Iran] ; Hossein Azadi [Iran] ; Morteza Izadi [Iran] ; Yunes Panahi [Iran] ; Saeid Fathi [Iran] ; Mahmood Salesi [Iran] ; Seyed Hassan Saadat [Iran] ; Amir Hossein Ghazale [Iran] ; Mohammad Rezapour [Iran] ; Abolfazl Mozafari [Iran] ; Nahid Zand [Iran] ; Mohammadreza Raesi Parsaei [Iran] ; Mohammad Hossein Ranjkesh [Iran] ; Ramezan Jafari [Iran] ; Fatemeh Movaseghi [Iran] ; Enayat Darabi [Iran]The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
000C15 (2020) Alem Zekarias [Suède] ; Sarah Watson [Suède] ; Sara Hedfors Vidlin [Suède] ; Birgitta Grundmark [Suède]Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
000E64 (2020) James M. Sanders [États-Unis] ; Marguerite L. Monogue [États-Unis] ; Tomasz Z. Jodlowski [États-Unis] ; James B. Cutrell [États-Unis]Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
000E86 (2020) Javed Akram [Pakistan] ; Shehnoor Azhar [Pakistan] ; Muhammad Shahzad [Pakistan] ; Waqas Latif [Pakistan] ; Khalid Saeed Khan [Espagne]Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.
000F54 (2020) Maryam Daneshpazhooh [Iran] ; Tahereh Soori [Iran] ; Ahdie Isazade [Iran] ; Pedram Noormohammadpour [Iran]Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
001166 (2020) Sherief Abd-Elsalam [Égypte] ; Eslam Saber Esmail [Égypte] ; Mai Khalaf [Égypte] ; Ehab Fawzy Abdo [Égypte] ; Mohammed A. Medhat [Égypte] ; Mohamed Samir Abd El Ghafar [Égypte] ; Ossama Ashraf Ahmed [Égypte] ; Shaimaa Soliman [Égypte] ; Ghada N. Serangawy [Égypte] ; Mohamed Alboraie [Égypte]Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
001265 (2020) Fatemeh Dehghani Firouzabadi [Iran] ; Mohammad Dehghani Firouzabadi [Iran] ; Babak Ghalehbaghi [Iran] ; Hesam Jahandideh [Iran] ; Maryam Roomiani [Iran] ; Sogand Goudarzi [États-Unis]Have the symptoms of patients with COVID-19 changed over time during hospitalization?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Oseltamivir" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Oseltamivir" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Oseltamivir
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021